Friday, 14 October 2016

EMA committee conditionally approves AbbVie leukemia drug

(Reuters) - AbbVie Inc won the conditional backing of an advisory committee of the European Medicines Agency (EMA) on Friday for a drug to treat a form of blood cancer.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)